Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sayana Press Self-Injection Feasibility in Malawi
NCT02293694Completed
- Sponsor
- FHI 360
- Start
- Sep 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dmpa-sc in pregnancy (2 arms), sponsored by FHI 360. Primary endpoint: Continuation rates of Sayana Press at 12 months. Started Sep 2015; status: completed.
02
Drugs
dmpa-sc
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT02293694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02293694.